Jonathan Witten, MD
Urology · Louisville, KYNPI 1851617732
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Medtronic at 34.2% of the total.
Across 122 payments — averaging $71.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$924
- Coloplast$723
- Teleflex LLC$439
- Cumberland Pharmaceuticals, Inc.$348
- Blue Earth Diagnostics$292
- plus $3K from 29 others
What the payments were for
- Travel & lodging$5256%
- Food & beverage$8,19093%
- Education$681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $3,006 |
| Boston Scientific | 11 | $924 |
| Coloplast | 7 | $723 |
| Teleflex LLC | 4 | $439 |
| Cumberland Pharmaceuticals, Inc. | 2 | $348 |
| Blue Earth Diagnostics | 5 | $292 |
| Urogen Pharma, Inc. | 4 | $264 |
| Myriad Genetic Laboratories, Inc. | 3 | $251 |
| Sanara Medtech Inc. | 2 | $250 |
| Procept Biorobotics Corporation | 2 | $223 |
| Endo Pharmaceuticals Inc. | 5 | $215 |
| Palette Life Sciences, Inc. | 1 | $173 |
| Accord Healthcare, Inc. | 4 | $160 |
| Axonics, Inc. | 2 | $151 |
| Johnson & Johnson | 3 | $151 |
| Ferring Pharmaceuticals Inc. | 1 | $150 |
| Stryker | 1 | $144 |
| Neotract Inc. | 1 | $129 |
| Sumitomo Pharma America, Inc. | 6 | $128 |
| Calyxo, Inc. | 1 | $98 |
| Laborie Medical Technologies Corp. | 1 | $76 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $71 |
| Verity Pharmaceuticals Inc. | 3 | $69 |
| Novartis | 3 | $64 |
| Endo USA, Inc. | 2 | $57 |
| Astellas Pharma US Inc | 3 | $50 |
| Tolmar, Inc. | 2 | $40 |
| Myovant Sciences Inc. | 2 | $32 |
| Bioprotect Medical, Inc. | 1 | $23 |
| Pfizer | 1 | $17 |
| Bayer | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $14 |
| KARL Storz Endoscopy-america | 1 | $13 |
| Baxter Healthcare | 1 | $12 |
| Antares Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$2,229
- ALTIS$575
- UroLift$528
- Caldolor$348
- CellerateRx$250
- JELMYTO$241
- AquaBeam Robotic System$173
- ADSTILADRIN$150
- AMS 700$149
- 1788$144
- ALTAVIVA$141
- SPACEOAR VUE$138
- AdVance XP$136
- Bulkamid$135
- Axonics r-SNM System$135
- XIAFLEX$132
- BRAC CDx$132
- Axumin$122
- CAMCEVI$107
- REZUM$101
How this compares
$8,783 in reported general payments places this provider in the 85th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 135 | $129,338 |
| GemtesaVibegron | 86 | $75,724 |
| Tamsulosin Hcl | 735 | $9,329 |
| Testosterone | 38 | $6,933 |
| Testosterone Cypionate | 117 | $5,733 |
| Finasteride | 289 | $3,376 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 127 | $2,386 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $1,882 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 32 | $1,344 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,155 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 192 | $1,063 |
| Ondansetron Hcl | 187 | $630 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $552 |
| Dutasteride | 13 | $520 |
| Oxybutynin Chloride | 75 | $485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $50 | $129,338135 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $128 | $75,72486 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 139 urology providers in Kentucky.
Other urology in Louisville
- Uzoma AneleLouisville$60K
- Kellen ChoiLouisville$17K
- Rosa ParkLouisville$16K
- Mohammed SaidLouisville$11K
- Terrance BlackfordLouisville$10K
- Jessica SchardeinLouisville$9K
- Morris JacksonLouisville$7K
- Thomas SlabaughLexington$102K
- Lee EvansHopkinsville$56K
- Patrick HensleyLexington$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.